CAD & Atherosclerosis

Conference Coverage

Novel Agent Lowered LDL Up to 72%

Major Finding: At 150 mg SAR236553/REGN727 once every 2 weeks, LDL dropped by a mean of 72% at 12 weeks, from a baseline of 124 mg/dL. Within...

Pages